Autopsy report · NCT03185117

Opioid Consumption After Hospital Discharge in Orthopedic Surgery

“Low patient retention rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months after it had already started.
• Ran for about 2 years 11 months before it stopped.
• 70 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Ohio State University

Sponsor type

University, hospital or other

Conditions

Opioid Use; Arthropathy of Knee; Arthropathy of Hip

Participants

70

Sites

1

Countries

United States

Trials that died the same way

• Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
  “High patient withdrawal rate” (73% match in meaning)
• The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak
  “low participation and retention rates” (64% match in meaning)
• Reiki for the Management of Neuropathic Pain
  “Study closed due to substantial decrease in the desired patient population.” (60% match in meaning)
• Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy
  “lack of patient population - slow accrual” (60% match in meaning)
• Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma
  “slow recruitment of patients” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.